Items 1 to 10 of about 714504
1. Pärna K, Põld M, Ringmets I: Physicians' views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982-2014 in Estonia. Tob Induc Dis; 2017;15:31
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Physicians' views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982-2014 in Estonia.
  • METHODS: Cross-sectional postal surveys were sent to all practising physicians in Estonia in 1982, 2002 and 2014 providing data from 3504, 2694, and 2865 physicians respectively.
  • RESULTS: The age-standardized prevalence of current smoking among men decreased from 39.6% in 1982 to 14.2% in 2014, and among women from 12.4 to 5.1%, respectively.
  • Compared with 1982, the proportion of physicians agreeing with statements that smoking is a major cause or one of the causes of IHD, lung cancer, or chronic bronchitis was significantly higher in 2002 and 2014.
  • CONCLUSION: From 1982 to 2014, physicians' attitudes towards the health risks of smoking improved in Estonia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Public Health. 2007 Jun 20;7:115 [17578582.001]
  • [Cites] Tob Induc Dis. 2008 Dec 29;4:13 [19114012.001]
  • [Cites] Int J Environ Res Public Health. 2013 Dec 30;11(1):429-55 [24380976.001]
  • [Cites] J Epidemiol. 2013;23(1):4-11 [23149752.001]
  • [Cites] Scand J Public Health. 2002;30(2):133-40 [12028862.001]
  • [Cites] Health Serv Res. 2001 Feb;35(6):1347-55 [11221823.001]
  • [Cites] Tob Induc Dis. 2008 Sep 09;4:9 [18822167.001]
  • [Cites] Scand J Public Health. 2003;31(2):149-55 [12745766.001]
  • [Cites] Can J Public Health. 2010 Jul-Aug;101(4):290-3 [21033533.001]
  • [Cites] BMJ. 1994 Oct 8;309(6959):901-11 [7755693.001]
  • [Cites] Eur J Public Health. 2004 Jun;14(2):201-3 [15230511.001]
  • [Cites] Patient Educ Couns. 2009 Jan;74(1):118-23 [18774670.001]
  • [Cites] BMC Health Serv Res. 2009 Sep 14;9:160 [19751504.001]
  • [Cites] Public Health. 2005 May;119(5):390-9 [15780327.001]
  • [Cites] Soz Praventivmed. 2005;50(6):378-88 [16398100.001]
  • [Cites] J Subst Abuse. 1990;2(2):201-15 [2136110.001]
  • (PMID = 28814949.001).
  • [ISSN] 2070-7266
  • [Journal-full-title] Tobacco induced diseases
  • [ISO-abbreviation] Tob Induc Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Attitudes / Estonia / Knowledge / Physicians / Smoking / Smoking-related disease
  •  go-up   go-down


2. QuickStats: Percentage* of Children and Teens Aged 6-17 Years Who Missed >10 Days of School in the Past 12 Months Because of Illness or Injury,<sup>†</sup> by Serious Emotional or Behavioral Difficulties Status<sup>§</sup> and Age Group - National Health Interview Survey, 2014-2016<sup>¶</sup>. MMWR Morb Mortal Wkly Rep; 2017 Nov 10;66(44):1239
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] QuickStats: Percentage* of Children and Teens Aged 6-17 Years Who Missed >10 Days of School in the Past 12 Months Because of Illness or Injury,<sup>†</sup> by Serious Emotional or Behavioral Difficulties Status<sup>§</sup> and Age Group - National Health Interview Survey, 2014-2016<sup>¶</sup>.
  • During 2014-2016, children aged 6-17 years whose parent or guardian indicated the child had serious emotional or behavioral difficulties (EBDs) were almost four times as likely to miss >10 days of school because of illness or injury compared with children without serious EBDs (13.4% compared with 3.5%).
  • Among children with serious EBDs, those aged 6-10 years were less likely (8.0%) to miss >10 days of school compared with children aged 11-14 years (15.6%) and children aged 15-17 years (19.5%).
  • Among children without serious EBDs those aged 15-17 years (4.7%) were more likely to miss >10 school days compared with children aged 6-10 years (3.0%) and children aged 11-14 years (3.3%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29120998.001).
  • [ISSN] 1545-861X
  • [Journal-full-title] MMWR. Morbidity and mortality weekly report
  • [ISO-abbreviation] MMWR Morb. Mortal. Wkly. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Shannon FQ 2nd, Horace-Kwemi E, Najjemba R, Owiti P, Edwards J, Shringarpure K, Bhat P, Kateh FN: Effects of the 2014 Ebola outbreak on antenatal care and delivery outcomes in Liberia: a nationwide analysis. Public Health Action; 2017 Jun 21;7(Suppl 1):S88-S93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of the 2014 Ebola outbreak on antenatal care and delivery outcomes in Liberia: a nationwide analysis.
  • <b>Objectives:</b> To determine access to antenatal care (ANC), deliveries and their outcomes before, during and after the 2014-2015 Ebola outbreak.
  • <b>Objectif :</b> Déterminer l'accès aux consultations prénatales (ANC), aux accouchements assistés et à leurs résultats avant, pendant et après l'épidémie d'Ebola de 2014 à 2015.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Med. 2016 Aug 02;13(8):e1002096 [27482706.001]
  • [Cites] Public Health Action. 2012 Mar 21;2(1):21-2 [26392940.001]
  • [Cites] Lancet. 2014 Dec 13;384(9960):2105 [25497191.001]
  • [Cites] PLoS Med. 2010 Aug 10;7(8):null [20711476.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1226-7 [25551595.001]
  • [Cites] PLoS Curr. 2015 Aug 04;7:null [26331094.001]
  • [Cites] BMC Int Health Hum Rights. 2011 Mar 09;11 Suppl 1:S11 [21410998.001]
  • [Cites] Lancet. 2007 Oct 20;370(9596):1453-7 [18064739.001]
  • [Cites] Ethiop J Health Sci. 2014 Sep;24 Suppl:93-104 [25489186.001]
  • [Cites] BMC Pregnancy Childbirth. 2015 Oct 12;15:254 [26459295.001]
  • [Cites] Indian J Community Med. 2009 Jan;34(1):15-8 [19876449.001]
  • [Cites] Int J Tuberc Lung Dis. 2015 Nov;19(11):1271-5 [26467577.001]
  • [Cites] PLoS One. 2016 Aug 17;11(8):e0157296 [27533499.001]
  • (PMID = 28744445.001).
  • [ISSN] 2220-8372
  • [Journal-full-title] Public health action
  • [ISO-abbreviation] Public Health Action
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [Keywords] NOTNLM ; ANC / SORT IT / caesarian section / delivery outcomes / operational research
  •  go-up   go-down


4. Wang XB, Hong LC, Wei YZ, Fu X, Bao XQ, Zhang J, Hu G, Wu SH, Cheng JQ: [Spectrum and case fatality of inpatients with malignant tumors from 1995 to 2014 in Shenzhen city]. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun 10;38(6):784-788
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spectrum and case fatality of inpatients with malignant tumors from 1995 to 2014 in Shenzhen city].
  • <b>Methods:</b> All the hospitalized malignant tumor patients including deaths, were monitored from 1995 to 2014 in Shenzhen, and data was analyzed by SPSS 20.0 software.
  • <b>Results:</b> There were 160 988 inpatients of malignant tumors between 1995 and 2014 in Shenzhen.
  • The top three hospitalized tumors were lung (13.64<i>%</i>), liver (11.13<i>%</i>) and breast (7.86<i>%</i>) cancers.
  • Numbers of the malignant tumor inpatients had been rapidly increasing during the past 20 years, 12.3 times in 2014 higher than in 1995.
  • The total number of deaths due to malignant tumors was 19 460.
  • Deaths of the top three malignant tumors were lung (24.40<i>%</i>), liver (19.84<i>%</i>) and colorectal (8.63<i>%</i>) cancers and the number of deaths was increasing, 12.5 times higher in 2014 than in 1995.
  • The APC of case fatality rate during 2003-2014 was -3.4<i>%</i>(95<i>%CI</i>: -7.6<i>%</i>-1.1<i>%</i>), but the decreasing trend (<i>t</i>=-1.63, <i>P</i>>0.05) was not statistically significant.
  • The number of male patients was significantly exceeding the females (<i>χ</i>(2)=41.691, <i>P</i><0.01), with sex ratio as 1.65∶1.
  • From age 35 and on, the number of deaths due to malignant tumors increased significantly, with the peak after 60 years of age.
  • <b>Conclusions:</b> The number of malignant tumor inpatients had an annual increase as well as the case fatality rate.
  • <b>目的:</b> 通过对1995-2014年深圳市住院恶性肿瘤病例进行疾病谱及病死率的分析,为本地区恶性肿瘤防治工作提供科学依据。 <b>方法:</b> 对1995-2014年深圳市恶性肿瘤住院及死亡情况进行监测,并采用SPSS 20.0软件对数据进行统计学分析。 <b>结果:</b> 1995-2014年深圳市共报告因恶性肿瘤住院病例160 988例,住院恶性肿瘤前三位依次为肺癌(13.64<i>%</i>)、肝癌(11.13<i>%</i>)、乳腺癌(7.86<i>%</i>)。20年间恶性肿瘤住院人数呈快速增长态势,2014年恶性肿瘤住院病例数是1995年的12.3倍。恶性肿瘤死亡总数19 460例,恶性肿瘤死亡前三位依次为肺癌(24.40<i>%</i>)、肝癌(19.84<i>%</i>)、结肠直肠癌(8.63<i>%</i>),20年间死亡人数也呈增长趋势,2014年死亡数是1995年的12.5倍。恶性肿瘤总病死率为12.09<i>%</i>。1995-2003年深圳市恶性肿瘤病死率年度变化百分比(APC)为9.7<i>%</i>(95<i>%CI</i>:2.0<i>%</i>~18.0<i>%</i>),呈上升趋势(<i>t</i>=2.72,<i>P</i><0.05),2003-2014年深圳市恶性肿瘤病死率APC=-3.4<i>%</i>(95<i>%CI</i>:-7.6<i>%</i>~1.1<i>%</i>),下降趋势无统计学意义(<i>t</i>=-1.63,<i>P</i>>0.05)。住院恶性肿瘤病死率前三位依次为肺癌(21.62<i>%</i>)、肝癌(21.39<i>%</i>)、食道癌(16.50<i>%</i>)。20年间白血病和肝癌病死率有所下降,肺癌、食道癌、胃癌、乳腺癌、结肠直肠癌及鼻咽癌病死率均有所增加。男性病死人数明显多于女性(<i>χ</i>(2)=41.691,<i>P</i><0.01),男∶女为1.65∶1。从35岁开始恶性肿瘤死亡人数显著增高,60岁后达到高峰。 <b>结论:</b> 恶性肿瘤住院及死亡病例逐年增加,病死率呈上升趋势,肺癌、肝癌恶性肿瘤死因位居前列,恶性肿瘤死亡集中在中老年人群。因此,应加强对肺癌、肝癌等重点癌种的防治工作。.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28647983.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Case fatality rate / Disease spectrum / Hospitalization / Malignancy
  •  go-up   go-down


5. Squire SB: CAHRD Consultation 2014: the 10-20 year Horizon Introduction and Overview - as circulated to Consultation participants. BMC Proc; 2015;9(Suppl 10):S2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CAHRD Consultation 2014: the 10-20 year Horizon Introduction and Overview - as circulated to Consultation participants.
  • The overall aim of the 2014 Consultation is to bring together internal and external partners to help shape the strategic direction for CAHRD over the 10 to 20 year horizon.
  • The major challenges that will need to be addressed over the next 10 to 20 years will be scoped and pathways to possible solutions proposed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Adolesc Health. 2013 May;52(5):517-22 [23608717.001]
  • [Cites] PLoS One. 2013 May 27;8(5):e63174 [23723975.001]
  • [Cites] PLoS Med. 2010 Jan 26;7(1):e1000221 [20126256.001]
  • [Cites] Int J Tuberc Lung Dis. 2011 Aug;15(8):996-1004 [21740663.001]
  • [Cites] Health Care Manag Sci. 2012 Sep;15(3):239-53 [22674467.001]
  • [Cites] PLoS Med. 2010 Nov 16;7(11):e1001000 [21124816.001]
  • [Cites] JAMA. 2013 Feb 13;309(6):594-604 [23403684.001]
  • [Cites] J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):577-83 [23337363.001]
  • [Cites] PLoS Med. 2011 Jul;8(7):e1000443 [21765808.001]
  • [Cites] PLoS Med. 2013;10(7):e1001488 [23935459.001]
  • [Cites] J Int AIDS Soc. 2010 Aug 23;13:32 [20731835.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Nov 14;11:CD000371 [23152203.001]
  • [Cites] Lancet Infect Dis. 2011 Mar;11(3):190-207 [21273130.001]
  • [Cites] PLoS One. 2014 Apr 04;9(4):e93083 [24705381.001]
  • [Cites] J Adolesc Health. 2011 Jan;48(1):79-86 [21185528.001]
  • [Cites] PLoS One. 2013 Nov 19;8(11):e79726 [24260293.001]
  • [Cites] N Engl J Med. 2011 Aug 11;365(6):493-505 [21767103.001]
  • [Cites] Health Res Policy Syst. 2014 Apr 17;12:19 [24739525.001]
  • [Cites] BMJ. 2001 Jul 14;323(7304):81-5 [11451782.001]
  • [Cites] AIDS Care. 2006 May;18(4):311-22 [16809108.001]
  • [Cites] Health Policy Plan. 2015 Mar;30(2):181-6 [24463334.001]
  • [Cites] Lancet. 2004 Jan 3;363(9402):9-17 [14723987.001]
  • [Cites] Health Res Policy Syst. 2010 May 13;8:12 [20465809.001]
  • [Cites] Reprod Health. 2014 Jan 02;11(1):1 [24383405.001]
  • [Cites] Health Educ Res. 2010 Dec;25(6):903-16 [20670997.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Jun 27;(6):CD009987 [23807693.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(9):e1806 [22970333.001]
  • [Cites] Lancet Infect Dis. 2013 Dec;13(12):1029-42 [24054085.001]
  • [Cites] PLoS One. 2012;7(9):e39746 [22962575.001]
  • (PMID = 28281700.001).
  • [Journal-full-title] BMC proceedings
  • [ISO-abbreviation] BMC Proc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


6. Bushnell GA, Stürmer T, Gaynes BN, Pate V, Miller M: Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014. JAMA Psychiatry; 2017 Jul 01;74(7):747-755
MedlinePlus Health Information. consumer health - Antidepressants.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.
  • Design, Setting, and Participants: This cohort study using a US commercial claims database included commercially insured adults (aged 18-64 years) from January 1, 2001, through December 31, 2014, with a recent depression diagnosis who began antidepressant therapy but had not used antidepressants or benzodiazepines in the prior year.
  • Results: Of the 765 130 adults (median age, 39 years; interquartile range, 29-49 years; 507 451 women [66.3%]) who initiated antidepressant treatment, 81 020 (10.6%) also initiated benzodiazepine treatment.
  • The mean annual increase in the proportion simultaneously starting use of both agents from 2001 to 2014 was 0.49% (95% CI, 0.47%-0.51%), increasing from 6.1% (95% CI, 5.5%-6.6%) in 2001 to 12.5% (95% CI, 12.3%-12.7%) in 2012 and stabilizing through 2014 (11.3%; 95% CI, 11.1%-11.5%).

  • Genetic Alliance. consumer health - Depression.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cochrane Database Syst Rev. 2001;(2):CD001026 [11405972.001]
  • [Cites] Ann Pharmacother. 2012 Apr;46(4):503-12 [22454448.001]
  • [Cites] Arch Gen Psychiatry. 1998 Dec;55(12):1128-32 [9862557.001]
  • [Cites] Age Ageing. 2010 Jul;39(4):488-94 [20511245.001]
  • [Cites] BMC Psychiatry. 2009 Jun 16;9:38 [19531229.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):7-15 [18980206.001]
  • [Cites] JAMA. 2016 May 24-31;315(20):2230-2 [27218634.001]
  • [Cites] Osteoporos Int. 2006;17(6):807-16 [16520889.001]
  • [Cites] BMJ. 2015 Jun 10;350:h2698 [26063215.001]
  • [Cites] Int J Drug Policy. 2014 May;25(3):569-74 [24412006.001]
  • [Cites] Arch Gen Psychiatry. 2005 Jun;62(6):617-27 [15939839.001]
  • [Cites] Addiction. 2011 Dec;106(12 ):2086-109 [21714826.001]
  • [Cites] Am J Epidemiol. 2004 Apr 1;159(7):702-6 [15033648.001]
  • [Cites] NCHS Data Brief. 2014 Sep;(166):1-8 [25228059.001]
  • [Cites] JAMA. 2013 Feb 20;309(7):657-9 [23423407.001]
  • [Cites] Am J Psychiatry. 1991 Feb;148(2):151-2 [1987812.001]
  • [Cites] Am J Epidemiol. 2013 Feb 15;177(4):292-8 [23371353.001]
  • [Cites] Int Rev Psychiatry. 2005 Jun;17(3):189-97 [16194790.001]
  • [Cites] J Subst Abuse Treat. 1991;8(1-2):53-9 [1675692.001]
  • [Cites] Ann Clin Psychiatry. 2008 Jul-Sep;20(3):157-69 [18633742.001]
  • [Cites] J Affect Disord. 2008 Sep;110(1-2):84-93 [18329721.001]
  • [Cites] J Clin Psychopharmacol. 2011 Jun;31(3):360-4 [21508865.001]
  • [Cites] J Affect Disord. 2002 Aug;70(3):251-9 [12128237.001]
  • [Cites] Am J Public Health. 2016 Apr;106(4):686-8 [26890165.001]
  • [Cites] Drug Alcohol Depend. 2012 Sep 1;125(1-2):8-18 [22857878.001]
  • [Cites] Drug Saf. 2007;30(2):171-84 [17253881.001]
  • [Cites] Am J Public Health. 2016 Nov;106(11):2019-2025 [27631754.001]
  • [Cites] J Clin Psychopharmacol. 2008 Aug;28(4):384-91 [18626264.001]
  • [Cites] J Clin Psychiatry. 2002 Mar;63(3):187-93 [11926716.001]
  • [Cites] J Clin Epidemiol. 2002 Oct;55(10):1049-53 [12464383.001]
  • [Cites] J Clin Psychiatry. 2010;71 Suppl E1:e04 [20371031.001]
  • [Cites] JAMA Psychiatry. 2015 Feb;72(2):136-42 [25517224.001]
  • [Cites] J Psychopharmacol. 2013 Nov;27(11):967-71 [24067791.001]
  • [Cites] Lancet. 1998 Oct 24;352(9137):1331-6 [9802269.001]
  • [Cites] Eur Psychiatry. 2015 Nov;30(8):1037-47 [26545257.001]
  • [Cites] BMC Psychiatry. 2013 Sep 23;13:231 [24053713.001]
  • [Cites] Gen Hosp Psychiatry. 2013 May-Jun;35(3):279-85 [23415578.001]
  • (PMID = 28593281.001).
  • [ISSN] 2168-6238
  • [Journal-full-title] JAMA psychiatry
  • [ISO-abbreviation] JAMA Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antidepressive Agents; 12794-10-4 / Benzodiazepines
  •  go-up   go-down


7. Shams-Beyranvand M, Farzadfar F, Naderimagham S, Tirani M, Maracy MR: Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models. J Diabetes Metab Disord; 2017;16:12
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models.
  • METHODS: This population-based study was conducted on the population living in the city of Isfahan in 2014.
  • Years of life lost due to premature mortality (YLLs) were calculated by multiplying the number of deaths due to IHDs (that was collected from death registration system (DRS) and was adjusted for incompleteness and misclassification) with life expectancy (that was extracted from the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) 2013).
  • Years lived with disability (YLDs) were calculated by multiplying the prevalent cases of IHDs in each age-sex group (that was calculated using the stepwise approach to non-communicable disease risk factor surveillance (STEPS)) with total disability weight of IHDs (that was calculated using the GBD 2013).
  • RESULTS: In 2014, the number of DALYs due to IHDs was 43517.71 years which was formed of 31891.79 years of YLLs and 11625.92 years of YLDs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Res Med Sci. 2015 Nov;20(11):1077-83 [26941812.001]
  • [Cites] Int J Epidemiol. 2010 Apr;39 Suppl 1:i7-10 [20348129.001]
  • [Cites] Lancet. 2015 Jan 10;385(9963):117-71 [25530442.001]
  • [Cites] PLoS Med. 2010 Apr 13;7(4):e1000262 [20405002.001]
  • [Cites] Glob Heart. 2014 Mar;9(1):91-9 [24977114.001]
  • [Cites] Neuroepidemiology. 2015 ;45(3):203-14 [26505984.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2197-223 [23245608.001]
  • [Cites] Arch Iran Med. 2014 May;17(5):304-20 [24784860.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2095-128 [23245604.001]
  • [Cites] Can J Cardiol. 2015 Sep;31(9):1151-9 [26321437.001]
  • [Cites] Int J Prev Med. 2016 Jul 29;7:96 [27563432.001]
  • [Cites] Int J Cardiol. 2016 Jul 1;214:265-9 [27077547.001]
  • [Cites] Arch Iran Med. 2014 Jan;17(1):7-15 [24444059.001]
  • [Cites] Am J Public Health. 2016 Jan;106(1):74-8 [26696288.001]
  • [Cites] HIM J. 2014;43(2):35-42 [24948664.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2063-6 [23245602.001]
  • [Cites] Lancet. 2015 Aug 22;386(9995):743-800 [26063472.001]
  • [Cites] Glob J Health Sci. 2012 Dec 21;5(2):134-44 [23445701.001]
  • [Cites] Bull World Health Organ. 2011 Feb 1;89(2):112-20 [21346922.001]
  • [Cites] Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):968-75 [25887346.001]
  • [Cites] Diabetes Res Clin Pract. 2014 Feb;103(2):319-27 [24447808.001]
  • (PMID = 28331842.001).
  • [ISSN] 2251-6581
  • [Journal-full-title] Journal of diabetes and metabolic disorders
  • [ISO-abbreviation] J Diabetes Metab Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Burden of disease / Disability-adjusted life years (DALYs) / Ischemic heart diseases (IHDs) / Years lived with disability (YLDs) / Years of life lost due to premature mortality (YLLs)
  •  go-up   go-down


8. Ye X, Kato K, Wong LY, Jia T, Kalathil A, Latremouille J, Calafat AM: Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014. Int J Hyg Environ Health; 2018 Jan;221(1):9-16

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
  • National Health and Nutrition Examination Survey (NHANES) participants 12 years of age and older since 1999-2000, but PFAS data using NHANES individual samples among children younger than 12 years do not exist.
  • To obtain the first nationally representative PFAS exposure data in U.S. children, we quantified serum concentrations of 14 PFAS including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA), in a nationally representative subsample of 639 3-11year old participants in NHANES 2013-2014.
  • We calculated geometric mean concentrations, determined weighted Pearson correlations, and used linear regression to evaluate associations of sex, age (3-5 vs 6-11 years), race/ethnicity (Hispanic vs non-Hispanic), household income, and body mass index with concentrations of PFAS detected in more than 60% of participants.
  • We detected PFOS, PFOA, PFHxS, and PFNA in all children at concentrations similar to those of NHANES 2013-2014 adolescents and adults, suggesting prevalent exposure to these PFAS or their precursors among U.S.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier GmbH.
  • [Cites] Chemosphere. 2013 May;91(6):802-8 [23473698.001]
  • [Cites] Environ Health Perspect. 2009 Dec;117(12):1873-82 [20049206.001]
  • [Cites] Environ Health Perspect. 2014 Feb;122(2):187-92 [24280536.001]
  • [Cites] Environ Health Perspect. 2012 May;120(5):752-7 [22271837.001]
  • [Cites] J Expo Sci Environ Epidemiol. 2010 Nov;20(7):589-97 [19865074.001]
  • [Cites] Environ Sci Technol. 2009 Apr 1;43(7):2641-7 [19452929.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1596-602 [18007991.001]
  • [Cites] Public Health Rep. 2014 Nov-Dec;129(6):482-5 [25364048.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1677-82 [18008003.001]
  • [Cites] Environ Sci Technol. 2009 Jun 1;43(11):4194-9 [19569351.001]
  • [Cites] Toxicol Sci. 2007 Oct;99(2):366-94 [17519394.001]
  • [Cites] Environ Sci Technol. 2013;47(23 ):13266-75 [24187954.001]
  • [Cites] Environ Res. 2010 Nov;110(8):773-7 [20800832.001]
  • [Cites] Chemosphere. 2011 May;83(10 ):1320-5 [21531441.001]
  • [Cites] Chemosphere. 2015 Jun;129:39-45 [25262531.001]
  • [Cites] Reprod Toxicol. 2009 Jun;27(3-4):231-8 [19049861.001]
  • [Cites] Environ Sci Technol. 2004 Sep 1;38(17 ):4489-95 [15461154.001]
  • [Cites] Environ Sci Technol. 2011 Oct 1;45(19):8160-6 [21534542.001]
  • [Cites] Environ Sci Technol. 2006 Jan 1;40(1):32-44 [16433330.001]
  • [Cites] Environ Int. 2015 Oct;83:176-82 [26159671.001]
  • [Cites] Environ Int. 2013 Feb;52:1-8 [23266910.001]
  • [Cites] Int J Hyg Environ Health. 2012 Feb;215(2):212-5 [22001330.001]
  • [Cites] Environ Health Perspect. 2010 Aug;118(8):1100-8 [20423814.001]
  • [Cites] Environ Health Perspect. 2009 Apr;117(4):660-7 [19440508.001]
  • [Cites] Environ Sci Technol. 2017 Jun 6;51(11):6387-6394 [28482666.001]
  • [Cites] Reprod Toxicol. 2009 Jun;27(3-4):212-30 [19429401.001]
  • [Cites] Environ Health Perspect. 2012 Apr;120(4):590-4 [22182702.001]
  • [Cites] Environ Pollut. 2014 Jan;184:327-34 [24095703.001]
  • [Cites] Environ Sci Technol. 2006 Feb 1;40(3):715-20 [16509308.001]
  • [Cites] Environ Sci Technol Lett. 2016 Oct 11;3(10 ):344-350 [27752509.001]
  • [Cites] Arch Environ Contam Toxicol. 2009 Nov;57(4):631-8 [19685096.001]
  • [Cites] Environ Res. 2012 Jul;116:93-117 [22560884.001]
  • [Cites] Environ Sci Technol. 2010 Jun 1;44(11):4341-7 [20441147.001]
  • [Cites] Int Arch Occup Environ Health. 2007 Feb;80(4):313-9 [16915390.001]
  • [Cites] Environ Sci Technol. 2007 Apr 1;41(7):2237-42 [17438769.001]
  • [Cites] Environ Res. 2016 Jul;148:351-359 [27111244.001]
  • [Cites] Toxicol Appl Pharmacol. 2004 Jul 15;198(2):231-41 [15236955.001]
  • [Cites] Environ Int. 2015 Nov;84:71-81 [26232143.001]
  • [Cites] Environ Res. 2015 Jan;136:264-73 [25460645.001]
  • [Cites] Environ Sci Technol. 2011 Oct 1;45(19):8151-9 [21682250.001]
  • [Cites] Int J Environ Res Public Health. 2013 Feb 07;10 (2):699-711 [23435591.001]
  • [Cites] J Environ Health. 2014 Dec;77(5):14-9 [25619022.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1670-6 [18008002.001]
  • [Cites] Arch Environ Contam Toxicol. 2012 Jul;63(1):1-12 [22402780.001]
  • [Cites] Environ Health Perspect. 2011 Jan;119(1):92-7 [20920951.001]
  • [Cites] Environ Sci Technol. 2017 May 2;51(9):5193-5204 [28325044.001]
  • [Cites] Environ Sci Technol. 2014 Aug 19;48(16):9600-8 [25026485.001]
  • [Cites] Chemosphere. 2016 Feb;144:1631-8 [26517392.001]
  • [Cites] Toxicol Lett. 2014 Oct 15;230(2):263-70 [24503008.001]
  • [Cites] Chemosphere. 2013 Feb;90(5):1603-9 [22990023.001]
  • [Cites] J Immunotoxicol. 2013 Oct-Dec;10 (4):373-9 [23350954.001]
  • [Cites] Crit Rev Toxicol. 2004 Jul-Aug;34(4):351-84 [15328768.001]
  • [Cites] Int J Hyg Environ Health. 2010 Jun;213(3):224-32 [20556880.001]
  • [Cites] Environ Sci Technol. 2009 Mar 15;43(6):2131-6 [19368225.001]
  • [Cites] Environ Toxicol Chem. 2014 Feb;33(2):243-67 [24114778.001]
  • [Cites] Environ Health Perspect. 2011 Oct;119(10):1466-71 [21665566.001]
  • [Cites] Environ Health Perspect. 2008 May;116(5):651-7 [18470314.001]
  • [Cites] Toxicol Appl Pharmacol. 2012 Jan 15;258(2):248-55 [22119708.001]
  • [Cites] Environ Sci Technol. 2006 Jun 15;40(12 ):3742-8 [16830536.001]
  • [Cites] Environ Pollut. 2014 Sep;192:171-8 [24952613.001]
  • [Cites] Environ Sci Technol. 2017 Apr 18;51(8):4482-4493 [28323424.001]
  • [Cites] Paediatr Perinat Epidemiol. 2014 Mar;28(2):146-56 [24320613.001]
  • [Cites] Am J Epidemiol. 2008 Jul 1;168(1):66-72 [18460444.001]
  • (PMID = 28993126.001).
  • [ISSN] 1618-131X
  • [Journal-full-title] International journal of hygiene and environmental health
  • [ISO-abbreviation] Int J Hyg Environ Health
  • [Language] eng
  • [Grant] United States / Intramural CDC HHS / / CC999999
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Biomonitoring / Exposure / NHANES / PFAS
  •  go-up   go-down


9. Zhang P, Zhang J: [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015]. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr 10;38(4):424-430
MedlinePlus Health Information. consumer health - Infectious Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015].
  • <b>Objective:</b> To analyze the current situation on infectious diarrhea other than cholera, dysentery, typhoid and paratyphoid (hereinafter referred to as Other Infectious Diarrheal Diseases) under the current monitoring program in China from 2014 to 2015, to provide evidence for developing strategies related to the control of these diseases.
  • <b>Results:</b> In 2014, a total of 867 545 infectious diarrhea cases were reported, with the incidence rate as 64.0/100 000.
  • While in 2015, a total of 937 616 infectious diarrhea cases were reported, and the incidence rate was 68.8/100 000.
  • Cases involved in all the age groups, with 53.7<i>%</i> (968 984/1 805 161) of the total reported cases below 5 years of age.
  • Laboratory-confirmed cases accounted for 9.5<i>%</i> (82 285/867 545) of the total and 9.3<i>%</i>(86 975/937 616) of the cases reported in 2014 and 2015 respectively.

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28468056.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Etiology / Infectious diarrhea / Surveillance
  •  go-up   go-down


10. Guan DX, Yu FH, Wang GL, Zhou J, Wang DY, Nie XL, Xu XW: [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014]. Zhonghua Er Ke Za Zhi; 2017 Jul 02;55(7):493-498
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
  • <b>Method:</b> Clinical data of hospitalized patients diagnosed as IBD in Beijing Children's Hospital from January 2000 to December 2014 were collected and retrospectively analyzed.
  • Patients were divided into six groups based on type of disease and year of admission: Group A1(CD, 2000-2004) included 12 patients, Group B1(CD, 2005-2009) included 11, Group C1(CD, 2010-2014) included 51; Group A2(UC, 2000-2004) included 17, Group B2(UC, 2005-2009) included 25, Group C2(UC, 2010-2014) included 68.
  • <b>Result:</b> A total of 184 IBD patients were included in the study, 74 had CD and 110 had UC.
  • The hospitalization constituent ratio of CD increased from 0.6/10 000 in Year 2000 to 2.9/10 000 in Year 2014.
  • The hospitalization constituent ratio of UC increased from 0.5/10 000 in Year 2001 to 3.9/10 000 in Year 2014.
  • Perianal disease occured in 31.1%(23/74) of CD patients; 81.1%(60/74) of CD patients had moderate/severe activity.
  • Severe UC(S3) was more common in Group A2(64.7%, 11/17), but moderate UC(S2) was more common in Group C2(48.5%, 33/68), the difference was statistically significant (<i>P</i>=0.001 7).
  • <b>目的:</b> 总结炎性肠病(IBD)患儿的临床资料,包括克罗恩病(CD)和溃疡性结肠炎(UC),分析其临床特点及变化趋势。 <b>方法:</b> 对2000年1月1日至2014年12月31日在北京儿童医院确诊的184例IBD住院患儿的临床资料进行回顾性分析,按照入院时间及疾病种类分为6组:A1组(CD,2000年1月1日—2004年12月31日)12例,B1组(CD,2005年1月1日—2009年12月31日)11例,C1组(CD,2010年1月1日—2014年12月31日)51例;A2组(UC,2000年1月1日—2004年12月31日)17例,B2组(UC,2005年1月1日—2009年12月31日)25例,C2组(UC,2010年1月1日—2014年12月31日)68例。分析比较6组IBD患儿的临床特点及变化。 <b>结果:</b> 184例IBD患儿中,CD 74例,UC 110例。CD的入院构成比从2000年的0.6/10 000上升至2014年的2.9/10 000;UC的入院构成比从2001年的0.5/10 000升至2014年的3.9/10 000,CD和UC的入院构成比呈逐渐上升的趋势(<i>P</i>=0.000 5和0.004 9)。61.4%(113/184)的IBD患儿属于早发IBD,极早发IBD和婴儿型IBD分别占41.8%(77/184)、26.6%(49/184)。CD患儿以回结肠型(47.3%,35/74)及非狭窄非穿透型(67.6%,50/74)为主,并且有31.1%(23/74)的患儿合并肛周病变,疾病活动程度以中-重度活动(81.1%,60/74)为主;UC患儿以广泛结肠型(59.1%,65/110)为主。A2组疾病活动程度以重度活动为主(64.7%,11/17),C2组以中度活动为主(48.5%,33/68),差异有统计学意义(<i>P</i>=0.002,<i>P</i><0.001 7)。 <b>结论:</b> 15年内北京儿童医院IBD患儿的入院构成比呈逐渐增加的趋势。婴儿型IBD及极早发IBD患儿所占比例较高。CD合并肛周病变常见且以中-重度活动为主,其手术率、肠梗阻、肠穿孔的发生率均明显高于UC患儿。UC病变范围广泛且疾病活动程度重。.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28728256.001).
  • [ISSN] 0578-1310
  • [Journal-full-title] Zhonghua er ke za zhi = Chinese journal of pediatrics
  • [ISO-abbreviation] Zhonghua Er Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Child / Colitis, ulcerative / Crohn disease / Inflammatory bowel diseases
  •  go-up   go-down